However, patients with Delta breakthrough infection who received two vaccine doses had significantly higher levels of NCP IgM compared to patients with booster vaccination and Omicron BA.1 infection (p<0.05) as well as patients with booster vaccination and Omicron BA.5 infection (p<0.01). This evidence concerns the gene CD40LG and infection.